🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Popularity Online

Retatrutide, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid British shipping. Sellers promote the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in users administering products of uncertain source.

Some experts stated the popularity for retatrutide could be connected to the rising cost of approved slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or prison.

Service Reaction and Content Removal

Based on TikTok, the service has removed problematic content and banned related keywords and search suggestions. The company said it was committed to keeping the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at residence.

After moments of joining one group, a seller shared WhatsApp details, where most transactions take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Product Details and Costs

Within these groups, posts show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has already encountered individuals harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may subject users to possibly serious health risks”.